Pembrolizumab (KEYTRUDA®) trials for Melanoma

All Pembrolizumab (KEYTRUDA®) trials · All Melanoma trials

Phase breakdown

Recruiting trials studying Pembrolizumab (KEYTRUDA®) for Melanoma

• A Beta-only IL-2 ImmunoTherapY Study
  NCT05086692 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
  NCT05280314 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
  NCT06697301 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 107 locations

Common questions

How many trials study Pembrolizumab (KEYTRUDA®) for Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.